Phillips T, Wang M, Robak T, Gallinson D, Stevens D, Patel K, Ramadan S, Wun C-C, Jurczak W, Smith SD. Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed / refractory mantle cell lymphoma: phase Ib trial. haematol [Internet]. 2020Sep.10 [cited 2024Oct.2];. Available from: https://haematologica.org/article/view/haematol.2023.284896